US 10428028
HDAC inhibitors
granted A61PA61P21/00A61P21/02
Quick answer
US patent 10428028 (HDAC inhibitors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P21/00, A61P21/02, A61P21/04, A61P25/00